Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanta Subbarao

Showing results (231-240 of 300) with videos related to

Pageof 30
Sort By:
The Journal of Infectious Diseases|January 19, 2013
A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trialAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.
Plos One|November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trialKatherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.
Journal of Hazardous Materials|January 23, 2025
Ultraviolet radiation vs air filtration to mitigate virus laden aerosol in an occupied clinical roomShane A Landry, Milan Jamriska, Vinay J Menon, et al.
Elife|September 3, 2020
Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolutionJohn Huddleston, John R Barnes, Thomas Rowe, et al.
Cell Reports|May 7, 2021
Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infectionJessie J-Y Chang, Daniel Rawlinson, Miranda E Pitt, et al.
Nature Immunology|July 12, 2011
Systems biology of vaccination for seasonal influenza in humansHelder I Nakaya, Jens Wrammert, Eva K Lee, et al.
Vaccine|June 9, 2020
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccinesPaul-Henri Lambert, Donna M Ambrosino, Svein R Andersen, et al.
Cell Host & Microbe|June 10, 2016
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer ProtectionCarole J Henry Dunand, Paul E Leon, Min Huang, et al.
Antiviral Research|March 16, 2022
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020Elena A Govorkova, Emi Takashita, Rod S Daniels, et al.
Influenza and Other Respiratory Viruses|February 13, 2026
Nomenclature for Tracking of Genetic Variation of Seasonal Influenza VirusesRichard A Neher, John Huddleston, Trevor Bedford, et al.
Pageof 30

Showing results (231-240 of 300) with videos related to

Sort By:
Pageof 30
The Journal of Infectious Diseases|January 19, 2013
A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trialAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.
Plos One|November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trialKatherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.
Journal of Hazardous Materials|January 23, 2025
Ultraviolet radiation vs air filtration to mitigate virus laden aerosol in an occupied clinical roomShane A Landry, Milan Jamriska, Vinay J Menon, et al.
Elife|September 3, 2020
Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolutionJohn Huddleston, John R Barnes, Thomas Rowe, et al.
Cell Reports|May 7, 2021
Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infectionJessie J-Y Chang, Daniel Rawlinson, Miranda E Pitt, et al.
Nature Immunology|July 12, 2011
Systems biology of vaccination for seasonal influenza in humansHelder I Nakaya, Jens Wrammert, Eva K Lee, et al.
Vaccine|June 9, 2020
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccinesPaul-Henri Lambert, Donna M Ambrosino, Svein R Andersen, et al.
Cell Host & Microbe|June 10, 2016
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer ProtectionCarole J Henry Dunand, Paul E Leon, Min Huang, et al.
Antiviral Research|March 16, 2022
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020Elena A Govorkova, Emi Takashita, Rod S Daniels, et al.
Influenza and Other Respiratory Viruses|February 13, 2026
Nomenclature for Tracking of Genetic Variation of Seasonal Influenza VirusesRichard A Neher, John Huddleston, Trevor Bedford, et al.
Pageof 30